Pharmaceutical company Futura Medical may be able to process its DermaSys technology through...
- Futura’s DermaSys could enter market as medical device
- Conservative win best for UK medtech, finds Verdict poll
- UK general election 2019: what the manifestos mean for medtech
- Roundtable: debating the benefits of the NHS’s newly launched AI lab
- GHO Capital raises €975m in largest European healthcare fund
3M to divest drug delivery business to Altaris Capital in $650m deal
US-based conglomerate 3M has finalised a deal to divest its drug delivery business for approximately $650m to an affiliate of investment firm Altaris Capital Partners.
Futura’s DermaSys could enter market as medical device
Pharmaceutical company Futura Medical may be able to process its DermaSys technology through a medical devices regulatory path, following surprising results from the phase III clinical trial of its erectile dysfunction (ED) gel MED2005.
Conservative win best for UK medtech, finds Verdict poll
A win for the Conservative party in Thursday’s general election would be the most promising outcome for the UK’s medtech industry, according to a poll of Verdict Medical Devices readers.
UK general election 2019: what the manifestos mean for medtech
Ahead of the UK’s general election on 12 December, the country’s three leading political parties have launched their leadership manifestos. Chloe Kent sifts through the manifestos with a fine-tooth comb to see what Conservative, Labour and Liberal Democrat governments would mean for the UK medical device industry.
Roundtable: debating the benefits of the NHS’s newly launched AI lab
British Prime Minister Boris Johnson has pledged £250m investment into an NHS AI lab, which will exist within NHSX, the service’s digital-focused segment. We spoke to a range of experts across the industry about this development, and whether it will be a worthwhile investment for the NHS.
GHO Capital raises €975m in largest European healthcare fund
European specialist healthcare investor Global Healthcare Opportunities (GHO) has announced the successful close of its second funding round at a hard cap of €975m, the largest specialist private equity fund dedicated to European healthcare.
Hologic to divest Cynosure medical aesthetics unit for $205m
Diagnostic products developer Hologic has agreed to sell its Cynosure medical aesthetics business for a total cash consideration of $205m.
EIT Health Accelerator programme recognised by UBI Global
The European Institute of Innovation and Technology Health (EIT Health) has had its accelerator programme recognised by Stockholm-based innovation intelligence company UBI Global in its latest World Benchmark Study of business incubation.
Google-Ascension patient data deal comes under federal scrutiny
The US Office for Civil Rights in the Department of Health and Human Services has initiated an investigation into the Project Nightingale cloud computing deal between Google and US healthcare network Ascension Health, which would give Google access to the detailed health information of millions of patients.
October’s top news stories
3M has completed the acquisition of wound care solutions provider Acelity and its KCI subsidiaries globally for around $6.7bn, and researchers from the Abramson Cancer Center of the University of Pennsylvania have found that liquid biopsy can help to predict the prognosis of glioblastoma(GBM). Medicaldevice-network.com wraps up key headlines from October 2019.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.